T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a Phase 1/2 clinical trial
SARS-CoV-2, the causative agent of COVID-19, has caused a global pandemic and safe, effective vaccines are urgently needed. Strong, Th1-skewed T cell responses can drive protective humoral and cell-mediated immune responses, and may reduce the potential for disease enhancement. Cytotoxic T cells cle...
| Main Authors: | , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Journal article |
| Language: | English |
| Published: |
Springer Nature
2020
|